Evolving importance of biologics and novel deliver systems in the face of microbial resistance

AAPS PharmSci

Volumn 4, Issue 4, 2002, Pages

  Bowersock, Terry L ^a  

^a PFIZER INC   (United States)

Author keywords

Animal health; Biologics; Novel delivery system; Vaccines

Indexed keywords

ADJUVANT; ANTIBIOTIC AGENT; ANTIGEN; BIOLOGICAL PRODUCT; LIPOSOME; NUCLEIC ACID; VACCINE;

ANIMAL DISEASE; ANTIBIOTIC RESISTANCE; BEEF CATTLE; BIOTECHNOLOGY; DAIRY CATTLE; DISEASE TRANSMISSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; FISH; FOOD CONTROL; FOOD INDUSTRY; FOOD SAFETY; GENE EXPRESSION; INFECTION; INFECTION CONTROL; INFECTION RISK; LIVESTOCK; NONHUMAN; POULTRY; REVIEW; SWINE; ANIMAL; ARTICLE; COMMUNICABLE DISEASE; DOMESTIC ANIMAL; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGY;

ANIMAL DISEASES; ANIMALS; ANIMALS, DOMESTIC; BIOLOGICAL PRODUCTS; COMMUNICABLE DISEASES; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MICROBIAL; VACCINES;

EID: 0036449332     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Prescott JF, Dowling PM. Agriculture's role in managing antimicrobial resistance: conference report. Can Vet J. 2000;41:191-197.
2. Aherne F. Antibiotics-Pro or Con? International Pigletter. 2001;21:55-56.
3. Levy SB. Multidrug resistance-sign of the times. N Engl J Med. 1998;338:1376-1378.
4. The Changing Face of the Beef Industry. Cattle Fax. Jan. 2002; Available at:
5. Ferber D. Drugless chickens make for healthier people. ScienceNow. December 19, 2001. Available at: http://sciencenow.sciencemag.org/cgi/content/full/2001/1219/3
6. National Chicken Council. Antibiotic treatment surges in Denmark as growth promotion ends. December 2001; Available at:
7. USDA APHIS Veterinary Services. Vaccination of Cattle Against Respiratory Disease Pathogens in U.S. Feedlots. Info Sheet. Washington, DC: Government Printing Office; 2000.
8. Ferber D. Superbugs on the hoof? Science. 2000;2889:792-794.
9. Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Veter Res. (France). 1999;30:299-316.
10. Chapman PA, Ellin M, Ashton R, Shafique W. Comparison of culture, PCR and immunoassays for detecting Escherichia coli O157 following enrichment culture and immunomagnetic separation performed on naturally contaminated raw meat products. Int J Food Microbiol. 2001;68:11-20.
11. Wang H, Li Y, Slavik MF. Efficacy of cetylpyridinium chloride in immersion treatment for reducing populations of pathogenic bacteria on fresh-cut vegetables. J Food Prot. 2001;64:2071-2074.
12. Kramer JM, Frost JA, Bolton FJ, Wareing DR. Campylobacter contamination of raw meat and poultry at retail sale: identification of multiple types and comparison with isolates from human infection. J Food Prot. 2000;63:1654-1659.
13. Grave K, Lingaas E, Bangen M, Ronning M. Surveillance of the overall consumption of antibacterial drugs in humans, domestic animals and farmed fish in Norway in 1992 and 1996. J Antimicrob Chemother. 1999;4:243-252.
14. Bilic V, Lipej Z, Valpotic I, Habrun B, Humski A, Njari B. Mycoplasmal pneumonia in pigs in Croatia: first evaluation of a vaccine in fattening pigs. Acta Veterinaria Hungarica. 1996;44:287-293.
15. Le Grand A, Kobisch M. Comparison of the effects of vaccination and pulse medication in a pig herd infected with Mycoplasma hyopneumoniae. Veter Res. (Paris). 1996;27:241-253.
16. Roof MB, Doitchinoff DD. Safety, efficacy, and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuis-containing vaccine. Am J Vet Res. 1995;56:39-44.
17. Methner U, Barrow PA, Berndt A, Steinbach G. Combination of vaccination and competitive exclusion to prevent salmonella colonization in chickens: experimental studies. J Food Microbiol. 1999;49:35-42.
18. Zhang-Barber L, Turner AK, Barrow PA. Vaccination for control of salmonella in poultry. Vaccine. 1999;17:2538-2545.
19. Slauch JM, Mahan MJ, Mekalanos JJ. In vivo expression technology for selection of bacterial genes specifically induced in host tissues. Methods Enzymol. 1994;235:481-492.
20. Shea JE, Hensel M, Gleeson C, Holden DW. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci U S A. 1996;93:2593-2597.
21. Chatfield SN, Strahan K, Pickard D, Charles IG, Hormaeche CE, Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathog. 1992;12:145-151.
22. Chatfield SN, Roberts M, Dougan G, Hormaeche C, Khan CM. The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella. Parasitology. 1995;110 Suppl:S17-24.
23. Bowersock TL, Martin S. Vaccine delivery to animals. Adv Drug Deliv Rev. 1999;38:167-194.
24. Zhao Z, Leong KW. Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci. 1996;85:1261-1270.
25. Estuningsih SE, Smooker PM, Wiedosari E, et al. Evaluation of antigens of Fascioloa gigantica as vaccines against tropical fasciolosis in cattle. Int J Parasitol. 1997;27:1419-1428.
26. Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger B-cell activation. Nature. 1995;374:546-549.
27. Sundquist B, Lovgren K, Morein B. Influenza virus ISCOMS, antibody response in animals. Vaccine. 1988;6:49-53.
28. Mumford JA, Jessett DM, Rollinson EA, Hannant D, Draper ME. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet Rec. 1994;134:158-162.
29. Pizza M, Giuliani MM, Fontana MR, et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine. 2001;19:2534-2541.
30. Freytag LC, Clements JD. Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 1999;2356:215-236.
31. Mrsny RJ, Daugherty AL, McKee ML, Fitzgerald DJ. Bacterial toxins as tools for mucosal vaccination. Drug Discov Today. 2001;7:247-258.
32. Bowersock TL, Shalaby WSW, Levy M, et al. Evaluation of an orally administered vaccine, sing hydrogels containing bacterial exotoxins of Pasteurella haemolytica, in cattle. Am J Vet Res. 1994;55:502-509.
33. Weng CN, Tzan YL, Liu SD, Lin SY, Lee CJ. Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs. Res Vet Sci. 1992;53:42-46.
34. Liao CW, Cheng IC, Heh KS, Lin FY, Weng CN. Release characteristics of microspheres prepared by co-spray drying Actinobacillus pleuropneumoniae antigens and aqueous ethylcellulose dispersion. J Microencapsul. 2001;18:285-297.
35. Hensel A, Stockhole-Zurwieden N, Petzoldt K, Lubitz W. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies against homologous aerosol challenge. Infect Immun. 1995;63:3048-3053.
36. Lee RW, Strommer J, Hodgins D, Shewen PE, Niu Y, Lo RY. Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A 1 leukotoxin in 50 fusion protein. Infect Immun. 2001;69:5786-5793.
37. Hood EE, Witcher DR, Maddock S, et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breed. 1998;4:301-312.
38. Bowersock TL, Martin S. Controlled release vaccines in veterinary medicine. In: Rathbone MJ, Gurny R, eds. Controlled Release Veterinary Drug Delivery: Biological and Pharmaceutical Considerations. Amsterdam, The Netherlands: Elsevier; 2000:269-310.
39. Nally JE, Artiushin S, Sheoran AS, et al. Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system. Vaccine. 2000;19:492-497.
40. Singh M, Briones M, O'Hagan, DT. A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. J Control Release. 2001;70:267-276.
41. Opdebeeck JP, Tucker IG. A cholesterol implant used as delivery system to immunize mice with bovine serum albumin. J Control Release. 1993;23,:271-279.
42. Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993;259:1745-1749.
43. Cox GJM, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle infected with plasmid DNA. J Virol. 1993;67:5664-5667.
44. Krishnan BR. Current status of DNA vaccines in veterinary medicine. Adv Drug Deliv Rev. 2000;43:3-11.
45. Chen SC, Jones DH, Fynan EF, et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol. 1998;72:5757-5761.
46. Halbur P, Thanawongnuwech R, Brown G, et al. Efficacy of antimicrobial treatments and vaccination regimens for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J Clin Microbiol. 2000;38:1156-1160.
47. Greene CE, Schultz RD, Ford RB. Canine vaccination. Vet Clin North Am Small Anim Pract. 2001;31:473-494.
48. Ford RB. Vaccines and vaccinations: the strategic issues. Vet Clin North Am Small Anim Pract. 2001;31:439-453.
49. Shao ZJ. Aquaculture pharmaceuticals and biologicals: current perspectives and future possibilities. Adv Drug Deliv Rev. 2001;50:229-243.
50. Van Oirschot JT. Present and future of veterinary viral vaccinology: a review. Vet Q. 2001;23:100-108.